Cite
HARVARD Citation
Vale, C. et al. (n.d.). 20LBA What is the current evidence for adding docetaxel or bisphosphonates to androgen deprivation therapy (ADT) in men with hormone sensitive prostate cancer? A systematic review and meta-analyses. European journal of cancer. pp. S719-S720. [Online].